click below
click below
Normal Size Small Size show me how
1.15 orange book
orange book codes
| Question | Answer |
|---|---|
| AA | Products in conventional dosage forms not presenting bioequivalence problems |
| AB, AB1, AB2, AB3.... | Products meeting necessary bioequivalence requirements |
| AN | Solutions and Powders for Aerosolization |
| AO | Injectable Oil Solutions |
| AP | Injectable aqueous solutions and, in certain instances, IV non-aqueous solutions |
| AT | Topical Products |
| B* | Drug products requiring further FDA investigation and review to determine therapeutic equivalence |
| BC | Extended-release dosage form (capsules, injectables, and tablets) |
| BD | Active ingredients and dosage forms w/ documented bioequivalence problems |
| BE | Delayed-release oral dosage forms |
| BN | Products in aerosol-nebulizer drug delivery systems |
| BR | Suppositories or enemas that deliver drugs for systemic absorption |
| BS | Products having drug standard deficiencies |
| BT | Topical products with bioequivalence issues |
| BX | Drug products for which the data are insufficient to determine therapeutic equivalence |